At a glance

A baseline hormone panel and follicle count describe different things. Here is how the four markers fit together, what they can and cannot tell you, and how to prepare for the conversation that turns them into a plan.

A baseline report often arrives as a short list of numbers: FSH, LH, AMH, and a follicle count from ultrasound. It is tempting to read them as a scorecard, where higher or lower settles something. They are better read as four different descriptions of the same system, each with its own blind spots. No single number, and no combination of numbers, tells you whether IVF will work for you.

This guide explains what each marker reflects, why they are interpreted together with your age and history, and how to turn the report into useful questions for the clinician who will actually make treatment decisions.

Four markers, four different jobs

It helps to separate the panel into two groups. AMH and antral follicle count are estimates of ovarian reserve — the pool of follicles that could respond to stimulation. FSH and LH are hormones measured in the same blood sample, and they are read in the context of the whole panel and the day of your cycle on which the sample was taken.

Marker What it reflects What it does not tell you
AMH (anti-Müllerian hormone) A blood marker used to estimate ovarian reserve Egg quality, or whether a pregnancy will occur
Antral follicle count (AFC) Small follicles visible on ultrasound, counted as another estimate of reserve How many eggs will be retrieved, or their quality
FSH (follicle-stimulating hormone) A hormone measured in a baseline panel, read alongside cycle timing and the rest of the results A stand-alone diagnosis, or a prediction of outcome
LH (luteinising hormone) A hormone measured in the same baseline panel, interpreted with FSH and the wider picture Anything meaningful in isolation

Two practical points follow. First, reference ranges are laboratory-specific: a value flagged as normal or abnormal on one report may sit differently on another, so compare your numbers against the range printed on your own report rather than a range found online. Second, the day of your cycle matters for a baseline panel, which is why the date of the sample belongs next to the result when you share records.

Why AMH and antral follicle count are read side by side

AMH and AFC are both markers used to estimate ovarian reserve, but they are not interchangeable and one does not replace the other. They come from different measurements — a blood test and an ultrasound — and they can disagree. A count depends partly on who is scanning and on the equipment; a hormone level depends on the assay and on when the sample was taken.

When the two point in the same direction, the picture is more consistent. When they diverge, that divergence is itself information the clinician will want to weigh, sometimes by repeating a measurement. This is one reason a single number copied out of a report is a weak basis for a decision: the value of these markers comes from how they sit together, and from whether they are stable over time.

FSH and LH: context, not a verdict

FSH and LH are hormones measured in a baseline panel, and their meaning depends heavily on where you are in your cycle and what else the panel shows. Reading FSH in isolation — especially against a reference range from a different laboratory — invites conclusions the number cannot support. LH is rarely informative on its own; it is interpreted with FSH and the wider clinical picture.

If your report includes other results, such as thyroid function or prolactin, those belong in the same conversation. A clinician reads the panel as a set, not line by line, and may ask for a repeat test if the timing or the pattern is unclear.

Age and history change what the same number means

Markers are interpreted together with age and clinical context by the treating clinician. The same AMH value can support a different conversation at 29 than at 42, because age carries information the hormone does not. A history of ovarian surgery, endometriosis, chemotherapy, or a previous stimulation cycle also changes how a result is read.

This is why online calculators and forum comparisons are a poor fit for an individual report. They strip out exactly the context that gives the numbers meaning.

Reserve, response and chance are three different questions

Much of the confusion around these markers comes from collapsing three separate questions into one.

  • Reserve is what AMH and AFC estimate: the size of the follicle pool. It is a description, not a prognosis.
  • Response is how your ovaries react to a stimulation protocol — how many follicles develop and how many eggs are retrieved. Response is influenced by reserve, but also by the protocol, dosing, and factors the baseline panel does not capture.
  • Chance is the probability of a live birth, which depends on egg and sperm quality, embryo development, uterine factors, and age. Reserve markers do not measure this directly.

A low reserve estimate does not by itself mean IVF cannot work, and a high one does not guarantee a good response or a pregnancy. If your planning includes embryo testing, the same caution applies: PGT-A assesses chromosome number in cells sampled from an embryo, and the HFEA notes that testing has limitations, can produce incorrect findings, and does not guarantee a successful pregnancy or a healthy child. Whether to use it is a discussion for your individual situation, not a default step.

Turning the report into a consultation you can use

The most useful preparation is not deciding what the numbers mean, but arriving with the right questions and a clean record. Interpretation and any protocol decision belong to the treating clinician; your job in advance is to make that conversation efficient.

Before the appointment

  • Collect the original reports, not screenshots, with the laboratory reference ranges and the date of each sample.
  • Note the cycle day for the blood test and the ultrasound, if you know it.
  • Write down your age at the time of testing and any relevant history: previous cycles, surgery, diagnoses, medication.
  • List what you actually want to know — for example, whether a repeat test is warranted, or how the results might shape timing.

Questions worth asking

  • How do these four results sit together in my case, and does anything need repeating?
  • Which of these numbers would change your recommended approach, and which would not?
  • What would you expect my response to stimulation to look like, and what would you plan if it differs?
  • Given my age and history, what should I understand about my chances — and what are the uncertainties?
  • If embryo testing is on the table, what would it change in my plan, and what are its limits?

If you are still assembling the panel, a practical checklist of pre-IVF tests for foreigners can help you see what is typically requested and what to bring. If your results point toward a low reserve estimate, it is worth reading why egg number is only one part of that discussion before you draw conclusions from a single figure.

Planning around timing, records and a remote conversation

For patients travelling to Thailand, the practical question is often sequencing: which tests to do at home, which to repeat on arrival, and how to discuss results before booking flights. A remote consultation is usually the sensible first step, because it lets a clinician review your existing reports and tell you what, if anything, needs to be repeated — and on which cycle day.

Records matter here. A dated, complete set of results with reference ranges is far more useful than a summary, and it reduces the chance of a test being repeated simply because the original could not be read. If you would like help organising reports, framing questions, or coordinating a remote appointment and the travel that follows a confirmed plan, the coordination team can assist with that practical layer. Clinicians interpret the results and make treatment decisions; coordination does not diagnose or prescribe.

One planning habit is worth keeping: record approximate dates for your cycle, tests and any medication changes, and do not alter medication on your own while waiting for a review. Bring the dates to the consultation — they are often as informative as the numbers themselves.

What the panel cannot do

These four markers are useful, but they are not a complete picture. They do not measure egg quality, sperm factors, uterine environment, or the many variables that shape an individual cycle. They are also not a substitute for a clinician reading your history. Used well, they narrow the questions worth asking and help you plan timing and travel realistically. Used as a score, they mislead.

Evidence trail

Sources & verification

Review current primary information and reconfirm provider services, fees and eligibility before booking.

01HFEA: Pre-implantation genetic testing for aneuploidy (PGT-A) ↗

Your next practical step

Bring your coordination questions.

Ask about appointments, records, travel or the practical arrangements for your visit.

Ask about coordination support →